SUMMARY

Mark Fishman, President of the Novartis Institutes for BioMedical Research, discusses developing the zebrafish as a research tool, academia-industry collaborations and perspectives on the future of drug development. Narrated by Sarah E. Allan. To listen to this podcast, visit http://www.biologists.com/DMM/podcasts/index.html.

This content is only available via PDF.

Supplementary information